Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6PEMIGATINIB

02 9Pemigatinib

03 3Ponatinib

04 3Ponatinibhydroklorid

05 3Put It Away

06 1RETIFANLIMAB-DLWR

07 1RUXOLITINIB (RUXOLITINIB PHOSPHATE)

08 6RUXOLITINIB PHOSPHATE

09 1Retifanlimab

10 1Retifanlimab

11 1Ruxolitinib

12 2Ruxolitinib Phosphate

13 1TAFASITAMAB

14 2Tafasitamab

15 1Tafasitamabum

16 1axatilimab-csfr

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : NIKTIMVO

FNCE
Not Confirmed
arrow

Brand Name : NIKTIMVO

arrow
FNCE
Not Confirmed

Incyte Corporation

Dosage Form : INJECTABLE;INTRAVENOUS

Brand Name : NIKTIMVO

Dosage Strength : 50 MG/ML

Packaging :

Approval Date :

Application Number : 761411

Regulatory Info :

Registration Country : USA

blank

02

Brand Name : PEMAZYRE

FNCE
Not Confirmed
arrow

Brand Name : PEMAZYRE

arrow
FNCE
Not Confirmed

Incyte Corporation

Dosage Form : TABLET;ORAL

Brand Name : PEMAZYRE

Dosage Strength : 4.5MG

Packaging :

Approval Date : 2020-04-17

Application Number : 213736

Regulatory Info : RX

Registration Country : USA

blank

03

Brand Name : PEMAZYRE

FNCE
Not Confirmed
arrow

Brand Name : PEMAZYRE

arrow
FNCE
Not Confirmed

Incyte Corporation

Dosage Form : TABLET;ORAL

Brand Name : PEMAZYRE

Dosage Strength : 9MG

Packaging :

Approval Date : 2020-04-17

Application Number : 213736

Regulatory Info : RX

Registration Country : USA

blank

04

Brand Name : PEMAZYRE

FNCE
Not Confirmed
arrow

Brand Name : PEMAZYRE

arrow
FNCE
Not Confirmed

Incyte Corporation

Dosage Form : TABLET;ORAL

Brand Name : PEMAZYRE

Dosage Strength : 13.5MG

Packaging :

Approval Date : 2020-04-17

Application Number : 213736

Regulatory Info : RX

Registration Country : USA

blank

05

Brand Name : Pemazyre

FNCE
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
FNCE
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Brand Name : Pemazyre

Dosage Strength : 13.5mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20191122000062

Regulatory Info : Approved

Registration Country : Sweden

blank

06

Brand Name : Pemazyre

FNCE
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
FNCE
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Brand Name : Pemazyre

Dosage Strength : 4.5mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20191122000048

Regulatory Info : Approved

Registration Country : Sweden

blank

07

Brand Name : Pemazyre

FNCE
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
FNCE
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Brand Name : Pemazyre

Dosage Strength :

Packaging :

Approval Date : 26/03/2021

Application Number : 20191122000055

Regulatory Info : Approved

Registration Country : Sweden

blank

08

Brand Name : Pemazyre

FNCE
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
FNCE
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Brand Name : Pemazyre

Dosage Strength : 4.5mg

Packaging :

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

09

Brand Name : Pemazyre

FNCE
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
FNCE
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Brand Name : Pemazyre

Dosage Strength : 9mg

Packaging :

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

10

Brand Name : Pemazyre

FNCE
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
FNCE
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Brand Name : Pemazyre

Dosage Strength : 13.5mg

Packaging :

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank